Watts PJ - Search Results

1

Scintigraphic demonstration of lactulose-induced accelerated proximal colon transit.

Barrow L, Steed KP, Spiller RC, Watts PJ, Melia CD, Davies MC, Wilson CG. Barrow L, et al. Among authors: watts pj. Gastroenterology. 1992 Oct;103(4):1167-73. doi: 10.1016/0016-5085(92)91500-4. Gastroenterology. 1992. PMID: 1397874

2

Quantitative, noninvasive assessment of antidiarrheal actions of codeine using an experimental model of diarrhea in man.

Barrow L, Steed KP, Spiller RC, Maskell NA, Brown JK, Watts PJ, Melia CD, Davies MC, Wilson CG. Barrow L, et al. Among authors: watts pj. Dig Dis Sci. 1993 Jun;38(6):996-1003. doi: 10.1007/BF01295712. Dig Dis Sci. 1993. PMID: 8389688 Clinical Trial.

3

Mebeverine decreases mass movements and stool frequency in lactulose-induced diarrhoea.

Washington N, Ridley P, Thomas C, Spiller RC, Watts PJ, Wilson CG. Washington N, et al. Among authors: watts pj. Aliment Pharmacol Ther. 1998 Jun;12(6):583-8. doi: 10.1046/j.1365-2036.1998.00340.x. Aliment Pharmacol Ther. 1998. PMID: 9678820 Clinical Trial.

4

Fourier transform-Raman spectroscopy for the qualitative and quantitative characterization of sulfasalazine-containing polymeric microspheres.

Watts PJ, Tudor A, Church SJ, Hendra PJ, Turner P, Melia CD, Davies MC. Watts PJ, et al. Pharm Res. 1991 Oct;8(10):1323-8. doi: 10.1023/a:1015872300730. Pharm Res. 1991. PMID: 1686649

5

Microencapsulation using emulsification/solvent evaporation: an overview of techniques and applications.

Watts PJ, Davies MC, Melia CD. Watts PJ, et al. Crit Rev Ther Drug Carrier Syst. 1990;7(3):235-59. Crit Rev Ther Drug Carrier Syst. 1990. PMID: 2073688 Review.

6

Nasal delivery of insulin using novel chitosan based formulations: a comparative study in two animal models between simple chitosan formulations and chitosan nanoparticles.

Dyer AM, Hinchcliffe M, Watts P, Castile J, Jabbal-Gill I, Nankervis R, Smith A, Illum L. Dyer AM, et al. Pharm Res. 2002 Jul;19(7):998-1008. doi: 10.1023/a:1016418523014. Pharm Res. 2002. PMID: 12180553

7

Development of a novel nasal nicotine formulation comprising an optimal pulsatile and sustained plasma nicotine profile for smoking cessation.

Cheng YH, Watts P, Hinchcliffe M, Hotchkiss R, Nankervis R, Faraj NF, Smith A, Davis SS, Illum L. Cheng YH, et al. J Control Release. 2002 Feb 19;79(1-3):243-54. doi: 10.1016/s0168-3659(01)00553-3. J Control Release. 2002. PMID: 11853935

8

PecSys: in situ gelling system for optimised nasal drug delivery.

Watts P, Smith A. Watts P, et al. Expert Opin Drug Deliv. 2009 May;6(5):543-52. doi: 10.1517/17425240902939135. Expert Opin Drug Deliv. 2009. PMID: 19413461 Review.

9

TARGIT technology: coated starch capsules for site-specific drug delivery into the lower gastrointestinal tract.

Watts P, Smith A. Watts P, et al. Expert Opin Drug Deliv. 2005 Jan;2(1):159-67. doi: 10.1517/17425247.2.1.159. Expert Opin Drug Deliv. 2005. PMID: 16296742

10

Intranasal delivery of recombinant human growth hormone (somatropin) in sheep using chitosan-based powder formulations.

Cheng YH, Dyer AM, Jabbal-Gill I, Hinchcliffe M, Nankervis R, Smith A, Watts P. Cheng YH, et al. Eur J Pharm Sci. 2005 Sep;26(1):9-15. doi: 10.1016/j.ejps.2005.03.014. Eur J Pharm Sci. 2005. PMID: 15970435

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

69 results

Search Page

Filters